Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 245

1.

Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects.

Albi A, Pasternak O, Minati L, Marizzoni M, Bartrés-Faz D, Bargalló N, Bosch B, Rossini PM, Marra C, Müller B, Fiedler U, Wiltfang J, Roccatagliata L, Picco A, Nobili FM, Blin O, Sein J, Ranjeva JP, Didic M, Bombois S, Lopes R, Bordet R, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Frisoni G, Jovicich J; PharmaCog Consortium.

Hum Brain Mapp. 2016 Aug 13. doi: 10.1002/hbm.23350. [Epub ahead of print]

PMID:
27519630
2.

Cognitive MMN and P300 in Mild Cognitive Impairment and Alzheimer's Disease: A High Density EEG-3D Vector Field Tomography Approach.

Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris IY, Hadjileontiadis LJ.

Brain Res. 2016 Jul 30. pii: S0006-8993(16)30534-0. doi: 10.1016/j.brainres.2016.07.043. [Epub ahead of print]

PMID:
27485659
3.

Data quality evaluation for observational multiple sclerosis registries.

Kalincik T, Kuhle J, Pucci E, Rojas JI, Tsolaki M, Sirbu CA, Slee M, Butzkueven H; MSBase Scientific Leadership Group and MSBase Study Group.

Mult Scler. 2016 Aug 1. pii: 1352458516662728. [Epub ahead of print]

PMID:
27481209
4.

Efficacy and Safety of Crocus sativus L. in Patients with Mild Cognitive Impairment: One Year Single-Blind Randomized, with Parallel Groups, Clinical Trial.

Tsolaki M, Karathanasi E, Lazarou I, Dovas K, Verykouki E, Karakosta A, Georgiadis K, Tsolaki A, Adam K, Kompatsiaris I, Sinakos Z.

J Alzheimers Dis. 2016 Jul 27. [Epub ahead of print]

PMID:
27472878
5.

European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease-the substudy protocols: NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow.

Meulenbroek O, O'Dwyer S, de Jong D, van Spijker G, Kennelly S, Cregg F, Olde Rikkert M, Abdullah L, Wallin A, Walsh C, Coen R, Kenny RA, Daly L, Segurado R, Borjesson-Hanson A, Crawford F, Mullan M, Lucca U, Banzi R, Pasquier F, Breuilh L, Riepe M, Kalman J, Molloy W, Tsolaki M, Howard R, Adams J, Gaynor S, Lawlor B.

BMJ Open. 2016 Jul 19;6(7):e011584. doi: 10.1136/bmjopen-2016-011584.

6.

Cerebral perfusion alterations and cognitive decline in critically ill sepsis survivors.

Pierrakos C, Attou R, Decorte L, Velissaris D, Cudia A, Gottignies P, Devriendt J, Tsolaki M, De Bels D.

Acta Clin Belg. 2016 Jun 3:1-6. [Epub ahead of print]

PMID:
27352195
7.

Cognitive Impairment in Multiple Sclerosis: A Review of Neuropsychological Assessments.

Korakas N, Tsolaki M.

Cogn Behav Neurol. 2016 Jun;29(2):55-67. doi: 10.1097/WNN.0000000000000097.

PMID:
27336803
8.

MCI patients in Europe: Medication and comorbidities. The DESCRIPA study.

Tsolaki M, Papaliagkas V, Frisoni G, Jones R, Touchon J, Spiru L, Vellaz B, Verhey F, Winblad B, Visser PJ.

Curr Alzheimer Res. 2016 Jun 2. [Epub ahead of print]

PMID:
27335041
9.

Five-year biomarker progression variability for Alzheimer's disease dementia prediction: Can a complex instrumental activities of daily living marker fill in the gaps?

Tarnanas I, Tsolaki A, Wiederhold M, Wiederhold B, Tsolaki M.

Alzheimers Dement (Amst). 2015 Nov 14;1(4):521-32. doi: 10.1016/j.dadm.2015.10.005. eCollection 2015 Dec.

10.

Disrupted Network Topology in Patients with Stable and Progressive Mild Cognitive Impairment and Alzheimer's Disease.

Pereira JB, Mijalkov M, Kakaei E, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Spenger C, Lovestone S, Simmons A, Wahlund LO, Volpe G, Westman E; AddNeuroMed consortium, for the Alzheimer's Disease Neuroimaging Initiative.

Cereb Cortex. 2016 Aug;26(8):3476-93. doi: 10.1093/cercor/bhw128. Epub 2016 May 13.

11.

Test-retest reliability of the default mode network in a multi-centric fMRI study of healthy elderly: Effects of data-driven physiological noise correction techniques.

Marchitelli R, Minati L, Marizzoni M, Bosch B, Bartrés-Faz D, Müller BW, Wiltfang J, Fiedler U, Roccatagliata L, Picco A, Nobili F, Blin O, Bombois S, Lopes R, Bordet R, Sein J, Ranjeva JP, Didic M, Gros-Dagnac H, Payoux P, Zoccatelli G, Alessandrini F, Beltramello A, Bargalló N, Ferretti A, Caulo M, Aiello M, Cavaliere C, Soricelli A, Parnetti L, Tarducci R, Floridi P, Tsolaki M, Constantinidis M, Drevelegas A, Rossini PM, Marra C, Schönknecht P, Hensch T, Hoffmann KT, Kuijer JP, Visser PJ, Barkhof F, Frisoni GB, Jovicich J.

Hum Brain Mapp. 2016 Jun;37(6):2114-32. doi: 10.1002/hbm.23157. Epub 2016 Mar 17.

PMID:
26990928
12.

Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.

Theofilou P, Giannouli V, Kolias S, Tsolaki M.

Health Psychol Res. 2015 Apr 13;3(1):1556. doi: 10.4081/hpr.2015.1556. eCollection 2015 Apr 13.

13.

The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume.

Lupton MK, Strike L, Hansell NK, Wen W, Mather KA, Armstrong NJ, Thalamuthu A, McMahon KL, de Zubicaray GI, Assareh AA, Simmons A, Proitsi P, Powell JF, Montgomery GW, Hibar DP, Westman E, Tsolaki M, Kloszewska I, Soininen H, Mecocci P, Velas B, Lovestone S; Alzheimer's Disease Neuroimaging Initiative, Brodaty H, Ames D, Trollor JN, Martin NG, Thompson PM, Sachdev PS, Wright MJ.

Neurobiol Aging. 2016 Apr;40:68-77. doi: 10.1016/j.neurobiolaging.2015.12.023. Epub 2016 Jan 11.

PMID:
26973105
14.

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.

Galluzzi S, Marizzoni M, Babiloni C, Albani D, Antelmi L, Bagnoli C, Bartres-Faz D, Cordone S, Didic M, Farotti L, Fiedler U, Forloni G, Girtler N, Hensch T, Jovicich J, Leeuwis A, Marra C, Molinuevo JL, Nobili F, Pariente J, Parnetti L, Payoux P, Del Percio C, Ranjeva JP, Rolandi E, Rossini PM, Schönknecht P, Soricelli A, Tsolaki M, Visser PJ, Wiltfang J, Richardson JC, Bordet R, Blin O, Frisoni GB; PharmaCog Consortium.

J Intern Med. 2016 Jun;279(6):576-91. doi: 10.1111/joim.12482. Epub 2016 Mar 4.

PMID:
26940242
15.

Gender effect in human brain responses to bottom-up and top-down attention using the EEG 3D-Vector Field Tomography.

Kosmidou VE, Adam A, Papadaniil CD, Tsolaki M, Hadjileontiadis LJ, Kompatsiaris I.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:7574-7. doi: 10.1109/EMBC.2015.7320145.

PMID:
26738045
16.

Phase-amplitude cross-frequency coupling in EEG-derived cortical time series upon an auditory perception task.

Papadaniil CD, Kosmidou VE, Tsolaki A, Tsolaki M, Kompatsiaris IY, Hadjileontiadis LJ.

Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:4150-3. doi: 10.1109/EMBC.2015.7319308.

PMID:
26737208
17.

Measuring Global Brain Atrophy with the Brain Volume/Cerebrospinal Fluid Index: Normative Values, Cut-Offs and Clinical Associations.

Orellana C, Ferreira D, Muehlboeck JS, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuronMed consortium and for the Alzheimer''s Disease Neuroimaging Initiative.

Neurodegener Dis. 2016;16(1-2):77-86. doi: 10.1159/000442443. Epub 2015 Dec 19.

PMID:
26726737
18.

Our experience with informative and communication technologies (ICT) in dementia.

Tsolaki M, Zygouris S, Lazarou I, Kompatsiaris I, Chatzileontiadis L, Votis C, Tzovaras D, Karakostas A, Karagkiozi C, Dimitriou T, Tsiatsios T, Dimitriadis S, Tarnanas I, Dranidis D, Bamidis P.

Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:131-9.

19.

Longitudinal Protein Changes in Blood Plasma Associated with the Rate of Cognitive Decline in Alzheimer's Disease.

Sattlecker M, Khondoker M, Proitsi P, Williams S, Soininen H, Kłoszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Dobson RJ.

J Alzheimers Dis. 2015;49(4):1105-14. doi: 10.3233/JAD-140669.

PMID:
26599049
20.

Quantitative validation of a visual rating scale for frontal atrophy: associations with clinical status, APOE e4, CSF biomarkers and cognition.

Ferreira D, Cavallin L, Granberg T, Lindberg O, Aguilar C, Mecocci P, Vellas B, Tsolaki M, Kłoszewska I, Soininen H, Lovestone S, Simmons A, Wahlund LO, Westman E; AddNeuroMed consortium and for the Alzheimer’s Disease Neuroimaging Initiative*.

Eur Radiol. 2016 Aug;26(8):2597-610. doi: 10.1007/s00330-015-4101-9. Epub 2015 Nov 11.

PMID:
26560730
Items per page

Supplemental Content

Loading ...
Write to the Help Desk